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Abstract 
Mannose receptor is a member of the C-type lectin receptor family involved in pathogen 
molecular-pattern recognition, and plays a critical role in shaping host immune response. 
Single nucleotide polymorphisms (SNPs) in the MRC1 gene may affect expression levels and 
differences in the structure and function of proteins in different individuals, thereby affecting 
individual susceptibility to pulmonary tuberculosis. However, to date, MRC1 polymorphisms 
associated with susceptibility to pulmonary tuberculosis have not yet been reported. The 
present study aimed to investigate potential associations of SNPs in the MRC1 gene with 
pulmonary tuberculosis in a Chinese population. Six SNPs  (G1186A, G1195A, T1212C, 
C1221G, C1303T and C1323T) in exon 7 of the MRC1 gene were genotyped using the PCR 
and DNA sequencing methods in the pulmonary tuberculosis patients and the healthy con-
trols. Linkage disequilibrium analysis was performed between polymorphic sites. The study 
found that the allele frequency of G1186A (rs34039386) of the MRC1 gene in a Chinese 
population was higher in the pulmonary tuberculosis group than the healthy control group. 
There was a significant difference in frequency distribution between the two groups (P = 
0.037; OR = 0.76; 95% CI, 0.58-0.98). Genotypic analysis also indicated that the AG genotypes 
in a Chinese population were significantly correlated with pulmonary tuberculosis (P < 0.01; 
OR = 0.57; 95% CI, 0.37-0.87). After adjustment for age and gender, G1186A sites were found 
to be dominant (P < 0.01; OR = 0.59; 95% CI, 0.40-0.87), over-dominant (P = 0.045; OR = 
0.69; 95% CI, 0.47-0.99) and additive models (P = 0.041; OR = 0.76; 95% CI, 0.59-0.99) in 
association with pulmonary tuberculosis. But, no association was found between the other 5 
SNPs (G1195A, T1212C, C1221G, C1303T and C1323T) and tuberculosis (P > 0.05). This 
study is the first to report that genetic variants in the MRC1 gene can be associated with 
pulmonary tuberculosis in a Chinese population, and may reduce the risk of infecting pul-
monary tuberculosis. This also provides a new experimental basis to clarify the pathogenesis 
of pulmonary tuberculosis. 
Key words: Mannose receptor; MRC1 gene; Tuberculosis; Single-nucleotide polymorphism; Chi-
nese. 
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Tuberculosis (TB) is one of the world's most se-
rious  public  health  threats.  Over  the  past  several 
years, China is most profoundly affected by TB. Each 
year,  the  new  cases  of  TB  account  for  18%  of  the 
world’s population [1]. Although about one third of 
the world’s population is thought to be infected with 
Mycobacterium tuberculosis (MTB), only 5-15% of peo-
ple develop clinically active TB during their lifetime 
[2]. Some evidence suggests that certain genetic fac-
tors  may  be  involved  in  innate  immunity  and  play 
important roles in susceptibility to TB at the individ-
ual level. Genetic studies showed that both genes and 
environmental factors are associated with the patho-
genesis of TB [3, 4]. Therefore, it is important to iden-
tify genes that mediate susceptibility to TB. 
TB  is  an  infectious  disease  caused  by  MTB, 
which  mainly  lives  on  the  monocyte/macrophage 
system. Cellular immunity is involved in resistance to 
infectious disease caused by MTB. Activated macro-
phages perceive the invasion of MTB and lead to ac-
tive and passive immune response, such as, antigen 
presenting,  T  cell  activation,  B  cell  activation,  the 
production  of  interleukin  (IL),  interferon  (IFN)  and 
transformation  growth  factor  (TGF)  [5].  So,  mono-
cyte/macrophage system plays a key role in the early 
identification of MTB and the incidence of pulmonary 
TB  [5].  Pattern  recognition  receptors  (PRRs)  are  lo-
cated on the surface of the macrophages and dendritic 
cells,  which  belong  to  the  body's  natural  immune 
system  and  are  the  core  of  the  receptor  molecules 
identifying the pathogen. Many classes of PRRs have 
been  described,  including  Toll-like  receptors  (TLR), 
NOD-like receptors (NLR) and C-type lectin receptors 
(CLR) [6-8]. Recently, polymorphisms in the TLR [3, 
9-18] and NLR [19, 20] genes have been shown to be 
associated with susceptibility to pulmonary TB. The 
mannose receptor (MR) belongs to CLR, and the pre-
disposition of MRC1 gene variants to pulmonary TB 
have not been reported yet. 
MR is a member of the CLR family, which plays 
an  important  role  in  innate  immunity  [21].  MR  is 
predominantly present on alveolar macrophages and 
dendritic cells and recognizes glycan structures con-
taining  mannose,  fucose  and  N-acetylglucoasmine, 
which are commonly found on the cell walls of path-
ogenic micro-organism such as mycobacteria, fungus, 
parasites,  and  yeast  [6,  22,  23].  MR  binds  to  man-
nose-capped  lipoarabinomannans  (ManLAM),  a  cell 
wall component of MTB [24, 25], loaded to the anti-
gen-presenting cells (APC), and then presented to T 
cells which play a role in immune response [26]. MR 
can also help macrophages to phagocytize MTB [27, 
28] and plays an important role in innate immunity 
[25, 26]. The MRC1 gene, encoding the human MR, is 
located on chromosome 10p12 and consist of 30 exons. 
Several  reports  have  shown  that  the  MRC1  gene  is 
associated  with  the  susceptibility  to  some  diseases, 
such as asthma, sarcoidosis and leprosy [29-31]. We 
speculated that the MRC1 gene may be an excellent 
candidate for susceptibility to TB, and tested for asso-
ciations  between  MRC1  polymorphisms  and  the 
pulmonary TB in our Chinese case-control analysis. 
Materials and Methods  
Patients and Control Subjects 
A total of 222 Chinese subjects with pulmonary 
TB, aged 18-66 years (mean age 37.5 ± 8.6 years) were 
recruited  from  the  Sixth  Hospital  of  Shaoxing  and 
Hangzhou  Red  Cross  Hospital.  The  diagnosis  of 
pulmonary  TB  was  made  according  to  established 
criteria [32], 98 cases were confirmed by the  M. tu-
berculosis cultures and 124 cases were diagnosed by 
chest X-ray and computed tomography (CT) revealing 
evidence of typical active tuberculosis. A total of 232 
healthy controls, aged 20-64 years (mean age 39.6 ± 9.4 
years)  were  recruited  from  the  Zhejiang  Hospital 
between October 2008 and July 2011 (Table 1).  
The early morning, fasting blood samples from 
the  patients  and  controls  were  collected  in  3.0  mL 
EDTA tubes and stored at -70 °C. For each gene pol-
ymorphisms,  it  was  ensured  that  the  final  selected 
samples of TB patients were similar to controls in the 
ratio of gender, age, presence of TB history of rela-
tives, BCG vaccination and Tuberculin skin test (>10 
mm). This study was approved by the Ethics Com-
mittee of the Faculty of Medicine (Zhejiang Universi-
ty, China), and informed consents were obtained from 
all subjects before blood sampling. 
Genotyping 
We acquired the MRC1 gene sequence by using 
the  NCBI  Gene  database  (http://www.ncbi.nlm. 
nih.gov/gene)  and  the  Ensemble  Genome  Browser 
Database (http://asia.ensembl.org). We also obtained 
the information of single nucleotide polymorphisms 
(SNPs)  in  this  gene  by  using  dbSNP  database 
(http://www.ncbi.nlm.nih.gov/snp/),  and  screened 
the  frequency  of  SNPs  by  using  HapMap  database 
(http://www.hapmap.org). 
Finally,  we  selected  six  SNPs  in  exon  7  of  the 
MRC1 gene, G1186A (rs34039386, Gly396Ser), G1195A 
(rs71497223,  Gly396Ser),  T1212C  (rs71497224, 
Ile404Ile),  C1221G  (rs34284571,  Leu407Phe),  C1303T 





Table 1. Characteristics of healthy controls and TB patients. 
Characteristics  Chinese population (n = 454) 
Patients  Controls   
(n = 222)  (n =232)  P value 
Age, years range (mean ± SD) 
 
18-66  20-64  0.534a 
(37.5 ± 8.6)  (39.6 ± 9.4)   
Gender ( female: male)  108:114  117:125  --- 
Sputum culture-proven  98 (44.1%)  ND  --- 
Chest X-ray and CT-proven   124(55.9%)  ND  --- 
Pulmonary TB  222 (100%)  ND  --- 
Tuberculin skin test (>10 mm), no. (%)  188 (86.7%)  ND  --- 
Presence of TB history of relatives, no. (%)  20 (9%)  29 (3.9%)  0.231b 
BCG vaccination, no. (%)  113 (50.9%)  128 (55.2%)  0.195b 
Data are reported as number with percent in parentheses, unless otherwise stated. TB: tuberculosis; ND: not determined. aDifference be-
tween total patients and controls (t test). bDifference between total patients and controls (χ2 test). 
 
 
SNPs in the MRC1 gene were analyzed by pol-
ymerase chain reaction (PCR) and direct sequencing. 
Genomic  DNAs  were extracted from the peripheral 
blood leukocytes with DNA extraction kit (QIAamp® 
DNA  Blood  Min  Kit,  Germany)  according  to  the 
manufacturer’s instruction.  
The  PCR  primer  included  forward: 
TTGAGGCTGCAATGAGACAT  and  reverse: 
AGTGTAAGGTAGACTGCTCT.  The  PCR  was  per-
formed by denaturing at 95 °C for 5 min, followed by 
35 cycles at 95 °C for 50 s, 63 °C for 50 s, and 72 °C for 
30 s, and a final extension at 72 °C for 10 min. The 
amplified products were purified with PCR cleaning 
kit (AxyPrep PCR cleaning kit, USA) and then identi-
fied by scanning with the ABI 3100 sequencer (Ap-
plied Biosystems, Carlsbad, CA, USA).  
Statistical Analysis 
The chi-square test was used to compare allele 
and  genotype  distribution  in  the  TB  patients  and 
control subjects by the two-tailed Fisher exact method 
with the GraphPad Prism version 5.01 software. The 
odd ratio (OR) and 95% confidence interval (CI) were 
calculated by Miettinen’s method. The value of OR is 
used to estimate the relative risk. If the value of OR is 
equal to 1, it indicates that the factor has no effect on 
the incidence of disease. If the value of OR is greater 
than 1, it indicates that the factor is a risk to the inci-
dence of disease. If the value of OR is less than 1, it 
indicates that the factor is protective.  
Pairwise linkage disequilibrium was calculated 
with  SNPstas  (http://bioinfo.iconcologia.net/ 
SNPstats), which was estimated by calculating pair-
wise based on D′(D′value is the relative size of the 
LD linkage disequilibrium, which is on behalf of the 
differences between the expected haplotype frequen-
cy and the observed haplotype frequency and scaled 
in [−1,1] range) and R (R is the correlation coefficient 
between alleles) that are  on behalf of the degree of 
linkage  disequilibrium  between  each  pair  of  SNPs 
[33]. Values of D′> 0.75 were considered to be strong 
pairwise  linkage  disequilibrium  and  we  construct 
haplotypes  between  each  pair  of  SNPs.  Haplotype 
frequencies  and  associations  were  calculated  with 
expectation-maximization  algorithm.  Using  logistic 
regression method, we calculated the allele combina-
tions of OR values and 95% CI referring to the highest 
frequency of haplotype allele and the additive genetic 
model. P value was calculated to estimate haplotype 
association with pulmonary TB. 
Results 
The MRC1 gene was amplified and sequenced by 
PCR in all samples. Six polymorphisms were found in 
this region. All MRC1 SNPs were in Hardy-Weinberg 
equilibrium in the control group and the pulmonary 
TB group (P > 0.05) (Table 2). The frequencies of the 
G/G, A/G and A/A genotypes for the G1186A site in 
the control group were 0.267, 0.517 and 0.216, respec-
tively, while, the frequencies of the three genotypes in 
the pulmonary TB group were 0.383, 0.423 and 0.194, 
respectively.  The  frequency  of  A/G  genotype  was 
lower  in  the  pulmonary  TB  group  than  the  control 
group and there was a significant difference between 
the two groups (P < 0.01; OR = 0.57; 95% CI, 0.37 - 
0.87),  but  the  frequency  of  A/A  genotype  was  not 
significantly different between the two groups (P  > 
0.05). No significant differences between patients and 
controls were observed in the genotype distribution of 




0.05) (Table 3). 
The allele frequency of  G for the G1186A was 
higher in the pulmonary TB group than the control 
group and there was a significant difference between 
the  two  groups  (P  =  0.037;  OR  =  0.76;  95%  CI, 
0.58-0.98) (Table 2). The allele frequencies of G1195A, 
T1212C, C1221G, C1303T and C1323T were not sig-
nificantly different between patients and controls (P > 
0.05) (Table 2). 
Table 2. Distribution of the MRC1 SNP allele frequencies in the TB group (n=222) and the control group (n=232) in a 
Chinese population. 
SNP sites  Allele  Controls N(Freq)  Patients N(Freq)  P value  OR (95% CI) 
G1186A  G  244(0.526)  264(0.595)  0.037  1 
A  220(0.474)  180(0.405)    0.76(0.58-0.98) 
HWE(P)  0.57  0.07     
G1195A  G  464(1.000)  441(0.993)  0.076  1 
A  0(0.000)  3(0.007)    7.37(0.38-143.1) 
HWE(P)  1.00  0.92     
T1212C  T  404(0.871)  376(0.847)  0.302  1 
C  60(0.129)  68(0.153)    1.22(0.84-1.77) 
HWE(P)  0.61  0.05     
C1221G  C  464(1.000)  441(0.993)  0.076  1 
G  0(0.000)  3(0.007)    7.37(0.38-143.1) 
HWE(P)  1.00  0.92     
C1303T  C  462(1.000)  441(0.993)  0.076  1 
T   0(0.000)  3(0.007)    7.37(0.38-143.1) 
HWE(P)  1.00  0.92     
C1323T  T  457(0.989)  434(0.977)  0.168  1 
C   5(0.011)  10(0.023)    2.11(0.73-6.21) 
HWE(P)  0.87  0.73     
SNP: single nucleotide polymorphism; HWE: Hardy-Weinberg equilibrium; OR: odd ratio; CI: confidence interval; N: number of alleles; 
Freq: frequency. P value and OR were obtained by Chi-square test. Two-tailed Fisher’s exact test was used because of small sample numbers. 
All of the MRC1 SNPs were in Hardy-Weinberg equilibrium. 
Table 3. Distribution of the MRC1 SNP genotype frequencies in the TB group (n=222) and the control group (n=232) in a 
Chinese population. 




GG  62(0.267)  85(0.383)    1 
AG  120(0.517)  94(0.423)  <0.01  0.57(0.37-0.87) 




GG  232(1.000)  219(0.986)    1 
AG  0(0.000)  3 (0.014)  0.076  7.42(0.38-144.5) 
AA  0(0.000)  0(0.000)  ---  --- 
T1212C 
 
TT  175(0.754)  163(0.734)    1 
CT  54(0.233)  50(0.225)  0.978  0.99(0.64-1.54) 
CC  3(0.013)  9(0.041)  0.068  3.22(0.86-12.1) 
C1221G 
 
CC  232(1.000)  219(0.986)    1 
CG  0(0.000)  3(0.014)  0.076  7.42(0.38-144.5) 
GG  0(0.000)  0(0.000)  ---  --- 
C1303T 
 
CC  232(1.000)  219(0.986)    1 
CT  0(0.000)  3(0.014)  0.076  7.42(0.38-144.5) 
TT  0(0.000)  0(0.000)  ---  --- 
C1323T 
 
TT  226(0.978)  212(0.955)    1 
CT  5(0.022)  10(0.045)  0.164  2.13(0.72-6.34) 
CC  0(0.000)  0(0.000)  ---  --- 
SNP: single nucleotide polymorphism; OR: odds ratios; CI: confidence intervals; N: number of alleles; Freq: frequency. P-value and OR were 





We performed logistic repression analysis with 
all SNPs using a recessive model adjusted for age and 
sex  and  observed  that  G1186A SNP  was  associated 
with the pulmonary TB in co-dominant, dominant (P 
< 0.01; OR = 0.59; 95% CI, 0.40-0 .87), over-dominant 
(P = 0.045; OR = 0.69; 95% CI, 0.47-0 .99) and additive 
model (P = 0.041; OR = 0.76; 95% CI ,0.59-0 .99) (Table 
4, Table 5). According to the minimum Akaike infor-
mation  criterion  (AIC),  this  genetic  model  was  the 
dominant mode. However, the genetic model of other 
SNPs did not correlate with the pulmonary TB (P > 
0.05). 
Pairwise LD between the 6 SNPs of the MRC1 
gene was calculated for the cases and controls in  a 
Chinese population (Figure 1). We found strong LD 
(D′> 0.75, P < 0.0001) between some pairs of markers 
in  the  MRC1  gene  including  G1186A  and  C1221G, 
G1186A  and  C1323T,  G1195A  and  T1212C,  G1195A 
and  G1221C,  G1195A  and  C1303T,  T1212C  and 
C1221G,  T1212C  and  C1303T,  C1221G  and  C1303T. 
Therefore,  based  on  logistic-regression  analyses,  we 
observed  that  the  haplotype  of  each  SNP  pair  was 
associated with  pulmonary TB (Table 6). We found 
that the frequency of the haplotype AGTCCT in the 
pulmonary  TB  group  was  higher  than  the  control 
group,  whereas,  the  frequency  of  the  haplotype 
GGTCCT, GGCCCT, GGTCCC in the pulmonary TB 
group was lower than the control group. All haplo-
types with the MRC1 gene polymorphisms showed no 





Figure 1. Linkage disequilibrium analysis of single-nucleotide polymorphisms (SNPs) in the MRC1 gene in a Chinese pop-
ulation. The number at the intersection of each pair of SNPs represents the pairwise D, D′, r
2 and P values between two 
SNPs. Values of D′ > 0.75 were considered to be strong pairwise linkage disequilibrium. 
 
 




Table 4. Association of MRC1 polymorphisms with TB in a Chinese population with logistic regression. 
SNP sites  Dominant modela  Recessive modela  Additive modela  Log-additive modela 
OR  P  OR  P  OR  P  OR  P 
(95% CI)     (95% CI)    (95% CI)    (95% CI)   
G1186A 
 
0.58  <0.01  0.88  0.56  0.68   0.045  0.76  0.041 
(0.39-0.87)    (0.56-1.39)    (0.47-0.98)    (0.59-0.99)   
T1212C  1.10   0.62  3.21  0.061  0.95   0.85  1.20   0.31 
(0.72-1.69)    (0.86-12.02)    (0.61-1.48)    (0.83-1.73)   
aAdjusted for age and sex. Freq: frequency; OR: odd ratio; CI: confidence interval. 
 
Table 5. The association of G1186A with TB in a Chinese population using logistic regression 
aAdjusted for age and sex. OR: odd ratio; 95% CI: 95% confidence interval; AIC: Akaike’s Information Criterion; BIC: Bayesian Information 
Criterion.  
 
Table 6. Haplotype frequencies of polymorphisms variants of the MRC1 gene in patients with TB (n=222) and healthy 
controls (n=232) in a Chinese population 






OR (95% CI)  P-valuea 
G1186A  G1195A  T1212C  C1221G  C1303T  C1323T 
1  A  G  T  C  C  T  0.4741  0.4054  0.4405  1.00  --- 
2  G  G  T  C  C  T  0.3857  0.4189  0.4020  1.24(0.93-1.65)  0.13 
3  G  G  C  C  C  T  0.1293  0.1464  0.1377  1.28(0.87-1.90)  0.21 
4  G  G  T  C  C  C  0.0108  0.0225  0.0166  2.42(0.80-7.30)  0.11 
Global haplotype association p-value: 0.063 




Recent studies have reported that MR plays an 
important role in innate and adaptive immunity [7]. 
These receptors activate immune response by extra-
cellular carbohydrate recognition that binds the gly-
can structures of microbial pathogens, and may play 
an  important  role  in  TB  infection  [23].  However, 
polymorphisms  in  the  MRC1  gene,  encoding  MR, 
have not been reported to be associated with pulmo-
nary TB. We postulated that  MRC1 polymorphisms 
may be associated with the development of pulmo-
nary TB. Six SNPs in exon 7 of the MRC1 gene were 
analyzed. The results showed that both the frequency 
of genotype (P = 0.037; OR = 0.76; 95% CI, 0.58-0.98) 
and allele (P < 0.01; OR = 0.57; 95% CI, 0.37-0.87) for 
the  G1186A  (rs34039386)  site  were  significantly  dif-
ferent between the pulmonary TB group and the con-
Modela  Genotype  Patients  Controls  OR (95% CI)  P   AIC  BIC 
Codominant  G/G  85(38.3%)  62 (26.7%)  1.00  0.029  628.1  640.4 
G/A  94(42.3%)  120(51.7%)  0.57(0.37-0.87)       
A/A  43 (19.4%)  50(21.6%)  0.63(0.37-1.06)       
Dominant  G/G  85(38.3%)  62(26.7%)  1.00  0.0084  626.2  634.4 
G/A-A/A  137(61.7%)  170(73.3%)  0.59(0.40-0.87)       
Recessive  G/G-G/A  179(80.6%)  182(78.5%)  1.00  0.56  632.8  641.1 
A/A  43(19.4%)  50(21.6%)  0.87(0.55-1.38)       
Overdominant  G/G-A/A  128(57.7%)  112(48.3%)  1.00  0.045  629.1  637.4 
G/A  94(42.3%)  120(51.7%)  0.69(0.47-0.99)       




trol group. The OR values of genotype and allele for 
G1186A were less than 1, indicating that MRC1 pol-
ymorphisms  have  effects  on  the  development  of 
pulmonary TB, and may reduce the risk of being in-
fected with pulmonary TB. 
The  G1186A  site  of  MRC1  is  non-synonymous 
mutation that changes Gly to Ser. The mutation of this 
site may change the function of MR, which may also 
affect  the  binding  of  MR  protein  to  polysaccharide 
structure on the MTB surface, thus, contributing to the 
secretion of anti-inflammatory factors. Meanwhile, we 
also  analyzed  association  between  the  established 
haplotype  of  MRC1  gene  and  the  incidence  of  pul-
monary  TB.  The  results  showed  that  haplotype 
AGTCCT, GGTCCT, GGCCCT and GGTCCC in the 
MRC1 gene had no significant association with pul-
monary TB (P > 0.05). In addition, the other 5 poly-
morphism sites of MRC1 gene [G1195A (rs71497223, 
Gly396Ser),  T1212C  (rs71497224,  Ile404Ile),  C1221G 
(rs34284571,  Leu407Phe),  C1303T  (Leu435Phe)  and 
C1323T (Asn441Asn)] also showed no significant as-
sociation with pulmonary TB (P > 0.05), suggesting 
that  these  polymorphism  sites  were  not  associated 
with susceptibility to pulmonary TB. 
Andrea et al. [29] found that the allele frequency 
of G1186A site in the exon 7 of MRC1 gene had sig-
nificant  disparity  between  leprosy  per  se  cases  and 
healthy  controls  in  the  Vietnamese  population  (P  = 
0.036, OR = 0.76; 95% CI, 0.60-0.96). The OR value was 
less than 1, and the results showed that this site has 
significant protective role for leprosy and may reduce 
the risk of leprosy infection. Similarly, the allele fre-
quency of G1186A site was also found to be signifi-
cantly  different  between  leprosy  per  se  cases  and 
healthy  controls  (P  =  0.016,  OR  =  1.34;  95%  CI, 
1.06-1.70)  in  the  Brazilian  population  [29].  The  OR 
value  was  more  than  1,  suggesting  that  this  poly-
morphism is associated with susceptibility to leprosy. 
Hattori et al. [30] reported that the allele frequency of 
G1186A site in the exon 7 of MRC1 gene had no sig-
nificant association with asthma in the Japanese pop-
ulation. We proposed that the individual differences 
caused by genetic factors, may be the key factor in the 
difference  of  disease  susceptibility  and  the  gene 
polymorphisms [4]. In the present study, we analyzed 
alleles, genotypes and haplotypes, and concluded that 
the G1186A polymorphism of MRC1 gene was asso-
ciated with TB, and may have a protective function.  
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